A new model of renal microvascular injury

Current Opinion in Nephrology and Hypertension

Volumn 7, Issue 4, 1998, Pages 457-462

  Nangaku, Masaomi ^a   Shankland, Stuart J ^b   Couser, William G ^b   Johnson, Richard J ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ELECTROLYTE BALANCE; ENDOTHELIUM CELL; FLUID BALANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY INJURY; MICROANGIOPATHY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THROMBOSIS; VASCULAR ENDOTHELIUM;

ANIMALS; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HUMANS; KIDNEY FAILURE, ACUTE; KIDNEY GLOMERULUS; MICROCIRCULATION;

EID: 0031829545     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041552-199807000-00018     Document Type: Review

References (55)

1. Takano T, Brady HR. The endothelium in glomerular inflammation. Curr Opin Nephrol Hypertens 1995; 4:277-286.
2. Savage COS, The biology of glomerulus: endothelial cells. Kidney Int 1994; 45:314-319.
3. Stewart RJ, Marsden PA. Vascular endothelial cell activation in models of vascular and glomerular injury. Kidney Int 1994; 45 (suppl 45):S37-44.
4. Sens YA, Miorin LA, Silva HG, Malheiros DM, Filho DM, Jabur P. Acute renal failure due to hemolytic uremic syndrome in adult patients. Renal Fail 1997; 19:279-282.
5. Arora P, Kher V, Rai PK, Singhal MK, Gulati S, Gupta A, Prognosis of acute renal failure in children: a multivariate analysis. Pediatr Nephrol 1997; 11:153-155.
6. Remuzzi G, Ruggenenti P. The hemolytic uremic syndrome. Kidney Int 1995; 47:2-19.
7. Boyce TG, Swerdlow DL, Griffin PM, Escherichia coli O157: H7 and the hemolytic-uremic syndrome. N Engl J Med 1995; 333:364-368.
8. Rondeau E, Peraldi M-N. Escherichia coli and the hemolytic-uremic syndrome. N Engl J Med 1996; 335:660-662.
9. Arbus GS. Association of verotoxin-producing E. coli and verotoxin with •• hemolytic uremic syndrome. Kidney Int 1997; 58 (suppl):S91-S96. A compact review of verotoxin involvement in HUS.
10. Obrig TG, Louise CH, Lingwood CA, Boyd B, Barley-Maloney L, Daniel TO. Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 1993; 268:15484-15488.
11. Hughson MD, Nadasdy T, McCarty GA, Sholer C, Min K-W, Silva F. Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kid Dis 1992; 20:150-158.
12. Heptinstall RH. Hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, and systemic sclerosis (systemic scleroderma). 4th edn. In: Pathology of the kidney. Vol, II. Heptinstall RH (editor). Boston: Little, Brown, and Co; 1992. pp. 1163-1234.
13. Farrugia E, Torres VE, Gastineau D, Michet CJ, Holley KE. Lupus anticoagulant in systemic lupus erythematosus: a clinical and renal pathological study. Am J Kid Dis 1992; 5:463-471.
14. Brandt JR, Avner ED. Hemolytic uremic syndrome and thrombotic thrombocytopenic purpura In: Immunologic renal diseases, Neilson EG, Couser WG (editors). Philadelphia: Lippincott-Raven Publishers; 1997. pp. 1161-1179.
15. Piette J-C, Cacoub P, Wechsler B. Renal manifestations of the antiphospholipid syndrome. Semin Arthritis Rheum 1994; 23:357-366.
16. Ruggenenti P, Remuzzi G. Malignant vascular disease of the kidney: nature of the lesions, mediators of disease progression, and the case for bilateral nephrectomy. Am J Kid Dis 1996; 27:459-475.
17. Honda K, Ando A, Endo M, Shimizu K, Higashihara M, Nitta K, Nihei H. Thrombotic microangiopathy associated with α-interferon therapy for chronic myelocytic leukemia. Am J Kid Dis 1997; 30:123-130.
18. Gerritsen ME, Bloor CM. Endothelial cell gene expression in response to injury. FASEB J 1993; 7:523-532.
19. Cotran RS, Pober JS. Effects of cytokines on vascular endothelium: their role in vascular and immune injury. Kidney Int 1989; 35:969-975.
20. Pall AA, Savage COS. Mechanisms of endothelial cell injury in vasculitis. Springer Semin Immunopathol 1994; 16:23-37.
21. Noris M, Remuzzi G. New insights into circulating cell-endothelium interactions and their significance for glomerular pathophysiology. Am J Kid Dis 1995; 26:541-548.
22. Zoja C, Corna D, Farina C, Sacchi G, Lingwood C. Doyle MP, et al. Verotoxin glycolipid receptors determine the localization of microangiopathic process in rabits given verotoxin-1. J Lab Clin Med 1992; 120:229-238.
23. Taylor F, Chang A, Ferrell G, Mather T, Catlett R, Blick K, Esmon CT. C4b-binding protein exacerbates the host response to Escherichia coli. Blood 1991; 78:357-363.
24. Siegler RL, Taylor Jr FB, Tesh VL. A baboon model ot Shiga-like toxin mediated hemolytic uremic syndrome [abstract]. J Am Soc Nephrol 1996; 7:1834.
25. Karpman D, Connell H, Svensson M, Scheutz F, Alm P, Svanborg C. The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Eschenchia coli O157:H7 infection. J Infect Dis 1997; 175:611-620.
26. Hertzke DM, Cowan LA, Schoning P, Fenwick BW. Glomerular ultrastructural lesions of idiopathic cutaneous and renal glomerular vasculopathy of greyhounds. Vet Pathol 1995; 32:451-459.
27. Matsuo S, Fukatsu A, Taub ML, Caldwell PRB, Brentjens JR, Andres G. Glomerulonephritis induced in the rabbit by antiendothelial antibodies. J Clin Invest 1987; 79:1798-1811.
28. Matsuda M. Experimental glomerular tissue injury induced by a immunization with cultured endothelial cell plasma membrane. Acta Pathol Jpn 1988; 38:823-839.
29. Nangaku M, Alpers CE, Pippin J, Shankland SJ, Adler S, Kurokawa K, •• et al. A new model of renal microvascular endothelial injury. Kidney Int 1997; 52:182-194. A report of the establishment of a new rat model of renal TMA gives detailed descriptive information on the model.
30. Sekiyama S, Yoshida F, Yuzawa Y, Fukatsu A, Suzuki N, Sakamoto N, Matsuo S. Mesangial proliferative glomerulonephritis induced in rats by a lentil lectin and its antibodies. J Lab Clin Med 1993; 121:71-82.
31. Golbus SM, Wilson CB. Experimental glomerulonephritis induced by in situ formation of immune complexes in glomerular capillary wall. Kidney Int 1979; 16:148-157.
32. Bretton R, Bariety J. Ultrastructural localization of concanavalin A in normal rat kidney - glomeruli and arterioles. J Ultrastruct Res 1974; 48:396-403.
33. Adler S, Eng B. Integrin receptors and function on cultured glomerular endothelial cells. Kidney Int 1993; 44:278-284.
34. Mitra D, Jaffe EA, Weksler B, Hajjar KA, Soderland C, Laurence J. • Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. Blood 1997; 89:1224-1234. Plasmas from patients with TTP and sporadic HUS, but not diarrheaassociated HUS, were found capable of inducing apoptosis in primary renal microvascular endothelial cells. In contrast, these plasmas did not affect the pulmonary or hepathic microvascular endothelial cells.
35. Laurence J, Mitra D, Apoptosis of microvascular endothelial cells in the pathophysiology of thrombotic thrombocytopenic purpura sporadic hemolytic uremic syndrome. Semin Hematol 1997; 34:98-105.
36. Gordjani N, Sutor AH, Zimmerhackl LB, Brandis M, Hemolytic uremic •• syndromes in childhood. Semin Thromb Hemost 1997; 23:281-293. A comprehensive review which covers a wide range of aspects of HUS.
37. Ruggenenti P, Lutz J, Remuzzi G. Pathogenesis and treatment of •• thrombotic microangiopathy. Kidney Int 1997; 51 (suppl 58):S97-S101. A general overview of TMA also provides a guideline for treatment.
38. Nevard CHF, Jurd KM, Lane DA, Philippou H, Haycock GB, Hunt BJ. Activation of coagulation and fibrinolysis in childhood diarrhoea-associated haemolytic uraemic syndrome. Thromb Haemost 1997; 78:1450-1455.
39. van Selten PA, van Hinsbergh VWM, van der Velden TJAN, van de Kar • NCAJ, Vermeer M, Mahan JD, et al. Effects of TNFalpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int 1997; 51:1245-1256. These authors developed a new method to isolate and purify large numbers of human GEN, which were cultured for evaluation of the cytotoxicity of verotoxin to GEN.
40. Anrather D, Millan MT, Palmetshofer A, Robson SC, Geczy C, Ritchie • AJ, et al. Thrombin activates nuclear factor-κB and potentiates endothelial cell activation by TNF. J Immunol 1997; 159:5620-5628. Thrombin enhanced the ability of TNF to induce E-selection expression in aortic endothelial cells, although it alone did not increase the protein levels of E-selection.
41. Louise CB, Tran MC, Obrig TG. Sensitization of human umbilical vein endothelial cells to Shiga toxin: involvement of protein kinase C and NF-κB. Infect Immun 1997; 65;3337-3344.
42. Nangaku M, Alpers CE, Pippin J, Shankland SJ, Adler S, Kurokawa K, •• et al. Rer al microvascular injury induced by antibody to glomerular endothelial cells is mediated by C5b-9. Kidney Int 1997; 52:1570-1578. Studies utilizing complement-sufficient, complement-depleted and C6-deficient animals revealed a critical role of C5b-9 in the pathogenesis of the new renal TMA model in rats.
43. Nangaku M, Alpers CE, Pippin J, Shankland SJ, Kurokawa K, Adler S, et al, CD59 protects glomerular endothelial cells from immune mediated thrombotic microangiopathy in rats, J Am Soc Nephrol 1998; 9:590-597.
44. Sheerin NS, Springall T, Carroll MC, Hartley B, Sacks SH. Protection against anti-glomerular basement membrane (GMB)-mediated nephritis in C3- and C4-deficient mice. Clin. Exp. Immunol 1997; 110:403-409. A fascinating study utilizing gene targeted mice revealed a significant contribution of complement components in the pathogenesis of anti-glomerular basement membrane disease.
45. Platt JL. A perspective on xenograft rejection and accommodation. Immunol Rev 1994; 141:127-149.
46. Sims PJ, Wiedmer T. Induction of cellular procoagulant activity by the membrane attack complex of complement Semin Cell Biol 1995; 6:275-282
47. Bick RL, Murano G. Physiology of hemostasis. Clin Lab Med 1994; 4:677-707.
48. Bach FH, Robson SC, Ferran C, Winkler H, Millan MT, Stuhlmeier KM, et al. Endothelial cell activation and thromboregulation during xenograft rejection. Immunol Rev 1994; 141:5-30.
49. Harrori R, Hamilton KK, McEver RP, Sims PJ. Complement proteins C5b-9 induces secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J Biol Chem 1989, 264:9053-9060.
50. Hamilton KK, Hattori R, Esmon CT, Sims PJ. Complement proteins C5b-9 induces vesiculation of the endothelial plasma membrane and expose catalytic surface for assembly of the prothrombinase enzyme complex. J Biol Chem 1990; 265:3809-3814.
51. Saadi S, Holzknecht RA, Patte CP, Stern DM, Platt JL. Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med 1995; 182:1807-1814.
52. Saadi S, Platt JL. Transient perturbation of endothelial integrity induced by natural antibodies and complement. J Exp Med 1995; 181:21-31.
53. Platt JL, Vercellotti GM, Lindman BJ, Oegema Jr TR, Bach FH, Dalmasso AP. Release of heparan sulfate from endothelian cells: implications for pathogenesis of hyperacute rejection. J Exp Med 1990; 171:1363-1368.
54. Proulx FTJ, Delage G, Lafleur L, Chicoine L, Randomized, controlled trial of antibiotic therapy for Escherichia coli O157:H7 entertitis. J Pediatr 1992; 121:299-303.
55. Armstrong GD, Rowe PC, Goodyer P, Orrbine E, Klassen TP, Wells G, MacKenzie A, et al. A phase I study of chemically synthesized verotoxin (Shiga-like toxin) pk-trisaccharide receptors attached to chromosorb for preventing hemolytic-uremic syndrome. J Infect Dis 1995; 171:1042-1045.